Viewing Study NCT02502812


Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2026-01-13 @ 8:11 PM
Study NCT ID: NCT02502812
Status: COMPLETED
Last Update Posted: 2017-05-08
First Post: 2015-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module